eComment. Septal reduction therapy for hypertrophic cardiomyopathy: the need of experienced centres

被引：0
|
作者：
Garcia-Villarreal, Ovidio A. [1 ]
机构：
[1] Hosp Cardiovasc Dis 34, IMSS, Dept Cardiac Surg, Monterrey, Mexico
来源：
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY | 2013年 / 16卷 / 01期
关键词：
D O I：
10.1093/icvts/ivs468
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：9 / 10
页数：2
相关论文
共 50 条
  • [1] PULMONARY HYPERTENSION IN HYPERTROPHIC CARDIOMYOPATHY: EFFECT OF SEPTAL REDUCTION THERAPY
    Geske, Jeffrey B.
    Konecny, Tomas
    Ommen, Steve
    Nishimura, Rick
    Gersh, Bernard
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1224 - E1224
  • [2] CYANOACRYLATE FOR NONSURGICAL SEPTAL REDUCTION THERAPY IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    Oto, A.
    Aytemir, K.
    Okutucu, S.
    Cil, B.
    Peynircioglu, B.
    Kaya, E. B.
    Deniz, A.
    Evranos, B.
    Sahiner, L.
    Kabakci, G.
    Tokgozoglu, L.
    Ozkutlu, H.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 147 : S70 - S71
  • [3] Mavacamten, an Alternative to Septal Reduction Therapy for Patients with Hypertrophic Cardiomyopathy
    Desai, Milind Y.
    Ali, Adel Hajj
    HEART INTERNATIONAL, 2023, 17 (01): : 2 - 4
  • [4] Non-surgical septal reduction therapy in hypertrophic cardiomyopathy
    Cooper, Robert M.
    Stables, Rodney H.
    HEART, 2018, 104 (01) : 73 - U235
  • [5] Impact of left atrial strain mechanics on exercise intolerance and need for septal reduction therapy in hypertrophic cardiomyopathy
    Saijo, Yoshihito
    Van Iterson, Erik
    Brizneda, Maria Vega
    Desai, Milind Y.
    Lever, Harry M.
    Smedira, Nicholas G.
    Wierup, Per
    Thamilarasan, Maran
    Popovic, Zoran B.
    Grimm, Richard A.
    Griffin, Brian P.
    Xu, Bo
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2022, 23 (02) : 238 - 245
  • [6] Septal Reduction Therapy for Obstructive Hypertrophic Cardiomyopathy: Volume Still Matters for Septal Myectomy
    See, Vincent Y. Y.
    Wang, Libin
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (10):
  • [7] Electrophysiologic consequences of nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy
    不详
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2000, 11 (11) : 1296 - 1296
  • [8] Reoperation Was an Effective Therapy in Patients with Obstructive Hypertrophic Cardiomyopathy After Septal Reduction Therapy
    Zhang, Yang
    Zhu, Changsheng
    Song, Changpeng
    Yin, Kunlun
    Zhang, Jian
    Huang, Manyun
    Zheng, Xinxin
    Lu, Jie
    Fang, Xiaonan
    Zhou, Zhou
    Wang Shuiyun
    Huang, Xiaohong
    CIRCULATION, 2021, 144
  • [9] Ethanol septal reduction for symptomatic hypertrophic cardiomyopathy
    Lakkis, NM
    Kleiman, NS
    Killip, DM
    Spencer, WH
    CIRCULATION, 1997, 96 (08) : 1203 - 1203
  • [10] Comparison of Surgical Ventricular Septal Reduction to Alcohol Septal Ablation Therapy in Patients with Hypertrophic Cardiomyopathy
    Bourque, Catherine
    Reant, Patricia
    Bernard, Anne
    Leroux, Lionel
    Bonnet, Guillaume
    Pernot, Mathieu
    Bisson, Arnaud
    Herbert, Julien
    Saint-Etienne, Christophe
    Lafitte, Stephane
    Fauchier, Laurent
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 172 : 109 - 114
12345